Prognostic value of lymph node density in high‐grade salivary gland cancers
- 16 January 2015
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 111 (6), 784-789
- https://doi.org/10.1002/jso.23874
Abstract
Background To investigate the role of lymph node density (LND) as an independent prognostic factor in high-grade salivary gland cancers. Methods All 87 patients with high-grade salivary gland cancers underwent curative surgery combined with neck dissection and most of them received postoperative radiotherapy or chemoradiotherapy. LND was calculated as the ratio of positive lymph nodes to total lymph nodes harvested. Clinicopathologic variables associated with cancer-specific survival (CSS) and overall survival (OS) were identified by univariate and multivariate analyses using the Cox-proportional hazards model. Results Salivary duct carcinoma was the most common tumor (54%), followed by carcinoma ex pleomorphic adenoma (22%), and others. The 5-year CSS and OS were 50.9% and 49.6%, respectively, during a median follow-up of 61 months. In univariate analysis, tumor site, pathologic nodal stage, overall tumor-node-metastasis (TNM) stage, primary tumor size >3 cm, lymphovascular invasion, perineural invasion, extranodal extension, number of metastatic lymph nodes, and LND >4.0 were significant prognostic factors for CSS and OS (P < 0.05 each). Tumor site, perineural invasion, and LND were independent prognostic factors for both CSS and OS in multivariate analysis (P < 0.01). Conclusion Our findings support the prognostic value of LND for high-grade salivary gland cancers. J. Surg. Oncol. 2015 111:784–789.Funding Information
- Asan Institute for Life Science (2014-0306)
- Ministry of Education, Science and Technology (NRF-2012R1A1A2002039)
This publication has 24 references indexed in Scilit:
- Predictors of cervical lymph node metastasis in salivary gland cancerHead & Neck, 2013
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome predictionCancer, 2008
- The Number of Metastatic Lymph Nodes and the Ratio Between Metastatic and Examined Lymph Nodes Are Independent Prognostic Factors in Esophageal Cancer Regardless of Neoadjuvant Chemoradiation or Lymphadenectomy ExtentAnnals of Surgery, 2008
- Prognostic Value of Nodal Ratios in Node-Positive Breast CancerJournal of Clinical Oncology, 2006
- Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph NodesJournal of Clinical Oncology, 2005
- Determinants of survival in parotid gland carcinoma: a population-based studyAmerican Journal of Otolaryngology, 2004
- Role of the Extended Lymphadenectomy in Gastric Cancer Surgery: Experience in a Single InstitutionAnnals of Surgical Oncology, 2003
- Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodesOral Oncology, 2002
- Salivary gland tumoursOral Diseases, 2002